Related Experiment Video

Updated: May 25, 2026

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice
08:02

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice

Published on: October 19, 2013

Pentoxifylline and prevention of hyperoxia-induced lung -injury in neonatal rats

Beatriz Almario1, Shu Wu, Jinghong Peng

  • 1Department of Pediatrics, Batchelor Children's Research Institute, University of Miami Miller School of Medicine, Miami, Florida, USA.

Pediatric Research
|February 11, 2012
PubMed

Insights

Pentoxifylline (PTX) significantly improved survival in newborn rats exposed to high oxygen, reducing lung injury and inflammation. This suggests PTX may be a potential therapy for bronchopulmonary dysplasia (BPD) in preterm infants.

Area of Science:

  • Neonatal Physiology
  • Pulmonary Medicine
  • Pharmacology

Background:

  • Oxygen exposure is a key factor in bronchopulmonary dysplasia (BPD) development.
  • Pentoxifylline (PTX) exhibits anti-inflammatory and antifibrotic properties.
  • The study investigated PTX's protective potential against hyperoxia-induced lung injury (HILI).

Purpose of the Study:

  • To evaluate the efficacy of pentoxifylline (PTX) in mitigating hyperoxia-induced lung injury in newborn rats.
  • To assess the impact of PTX on lung edema, inflammation, antioxidant enzyme activity, and vascularization.
  • To determine if PTX can improve survival rates in a model of neonatal lung injury.

Main Methods:

  • Newborn rats were exposed to hyperoxia (>95% O2) and treated with PTX or saline.
  • Lung tissue was analyzed for edema, antioxidant enzyme (AOE) activity, and vascular endothelial growth factor (VEGF) expression.
  • Macrophage infiltration, vascularization, and alveolarization were assessed at day 9.

Main Results:

  • PTX treatment increased survival from 54% to 88% during hyperoxia.
  • PTX significantly reduced lung edema and macrophage infiltration, indicating decreased inflammation.
  • PTX enhanced antioxidant enzyme activities (SOD, CAT, GPX) and promoted pulmonary vascularization and VEGF expression.

Conclusions:

  • PTX demonstrates a protective effect against hyperoxia-induced lung injury in neonatal rats.
  • Reduced lung edema, inflammation, increased antioxidant capacity, and improved vascularization contribute to PTX's benefits.
  • PTX shows promise as a therapeutic agent for managing features of bronchopulmonary dysplasia in preterm newborns.
Abstract

Related Concept Videos

Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...